ADAR1 Capital Management »

Female Health shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Female Health (VERU) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Female Health

Tip: Access up to 7 years of quarterly data

All positions including Female Health held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Female Health by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $235k 336k 0.70
2023-12-31 $360k 500k 0.72

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Female Health

BlackRock
BlackRock
Perceptive Advisors
Vanguard Group
Geode Capital Management
Morgan Stanley
Rosalind Advisors
Altium Capital Management
State Street Corporation
Deutsche Bank Aktiengesellschaft
Northern Trust
Ikarian Capital
Cambridge Investment Research Advisors
Alpine Partners VI
Pvg Asset Management

View all funds holding Female Health